Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Update

Psyence Biomedical Ltd. (NASDAQ:PBM) saw a large decline in short interest in July. As of July 15th, there was short interest totalling 239,600 shares, a decline of 36.8% from the June 30th total of 378,900 shares. Based on an average trading volume of 644,800 shares, the days-to-cover ratio is currently 0.4 days. Currently, 5.1% of the company’s stock are short sold.

Psyence Biomedical Stock Performance

Psyence Biomedical stock traded down $0.01 during trading hours on Friday, hitting $0.59. The company had a trading volume of 1,337,377 shares, compared to its average volume of 2,975,854. Psyence Biomedical has a fifty-two week low of $0.27 and a fifty-two week high of $4.31. The company’s fifty day moving average is $0.54.

Institutional Trading of Psyence Biomedical

A hedge fund recently bought a new stake in Psyence Biomedical stock. Virtu Financial LLC bought a new position in Psyence Biomedical Ltd. (NASDAQ:PBM) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 26,419 shares of the company’s stock, valued at approximately $30,000. Virtu Financial LLC owned about 0.30% of Psyence Biomedical at the end of the most recent reporting period. Institutional investors and hedge funds own 77.44% of the company’s stock.

Psyence Biomedical Company Profile

Newcourt Acquisition Corp is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Newcourt Acquisition Corp is based in Oakland, California.